Liashko: Russia seeks to deprive Ukrainians of access to essential medicines

Ukraine’s pharmaceutical sector has faced more attacks during the past month, according to Health Minister Viktor Liashko. The reported targets are not limited to one type of facility. They include warehouses, manufacturing plants, and locations where valuable or critically important medicines are stored.

These sites perform different jobs, but they are connected. Production facilities make medicines. Warehouses hold supplies before distribution. Storage sites protect stocks needed by hospitals, pharmacies, and patients. Damaging any of them can interrupt access, even when other parts of the system remain operating.

The article gives a specific example from Sumy. A Russian attack on October 4 destroyed the KUSUM pharmaceutical plant and killed one employee. Liashko said the wider strikes place extra pressure on Ukraine’s healthcare system and require an appropriate response from the international community. He also urged partners to continue supporting Ukraine.

Essential medicines are treatments considered necessary for common, serious, or ongoing health needs. They can include medicines for chronic conditions and drugs used during urgent treatment. Their importance comes from their role in preventing worsening illness, controlling symptoms, and supporting timely medical care.

People with chronic diseases may need the same medicines regularly. If supplies seem threatened, they may try to buy extra doses in advance. Patients with sudden illnesses or emergencies may also depend on basic drugs being available immediately. When access fails, treatment can be delayed or interrupted.

The article does not provide a formal list of essential medicines. It reports that attacks threaten Ukrainians’ access to basic medicines, drugs, and treatment when they need them most. Liashko said these disruptions also affect the wider healthcare system, because changing demand makes it harder to match available supplies with patients’ needs.

The article describes a broad disruption across Ukraine’s medicine-supply system. It does not present the crisis as damage to one isolated factory. Liashko says attacks have targeted pharmaceutical warehouses, production facilities, and sites storing valuable, critically important medicines.

Each part supports access in a different way. Production creates new supplies. Warehouses hold products for later movement. Storage sites preserve medicines until hospitals, pharmacies, or other users need them. Damage across these locations can create shortages, delays, and sudden changes in what is available, even if some facilities continue working.

The destruction of the KUSUM pharmaceutical plant in Sumy illustrates the problem, but the minister describes attacks against the sector more generally. He also says the resulting pressure affects the entire healthcare system. Partners’ continued support is therefore important, while Ukraine is maintaining healthcare reforms and sharing its crisis experience.

Pharmaceutical warehouses, plants, and storage sites are points where medicines are made, held, or prepared for use. If they are destroyed, medicines may be lost before reaching hospitals, pharmacies, or patients. New production may also be delayed when a manufacturing facility is damaged.

The key mechanism is a break in supply. Fewer medicines are available, deliveries may be interrupted, and healthcare providers must respond to sudden changes in demand and supply. Patients can then struggle to obtain treatment, especially when they need a medicine regularly or urgently. Damage to stored stocks adds another immediate loss.

Liashko said people with chronic diseases are trying to purchase medicines in advance. That behavior can increase pressure on remaining supplies. The article reports that the October 4 attack on Sumy destroyed the KUSUM pharmaceutical plant and killed one employee, showing the human cost alongside the supply disruption.

Stockpiling means patients buy medicines earlier or in larger amounts because they fear future shortages. For people with chronic diseases, this may feel necessary to avoid an interruption in regular treatment. But widespread advance purchasing can quickly reduce the supplies available to others.

The main mechanism is a mismatch between demand and supply. Attacks can destroy stocks or interrupt deliveries, while patient purchasing increases demand immediately. Healthcare providers and suppliers must then identify changing needs, move limited products, and respond to gaps. This makes planning and fair access more difficult.

Liashko said the destruction of medicine stocks places an additional burden on the entire healthcare system. He specifically noted that people with chronic diseases try to purchase needed medicines in advance. The system must respond promptly to these sudden demand changes and supply disruptions, while partners help Ukraine maintain care during the crisis.

The article’s clearest response is continued international support. Liashko said no healthcare system can manage alone with a crisis of this scale, and he urged partners to keep supporting Ukraine. That support can help replace destroyed stocks and sustain treatment while attacks continue.

In practice, resilience also depends on reducing reliance on any single site. Partners can help procure medicines from multiple sources, maintain reserves in safer locations, and arrange alternative transport and distribution routes. Healthcare authorities can coordinate demand information so scarce supplies reach urgent and chronic-care patients first. These measures are general supply-protection approaches, not specific actions listed in the article.

Ukraine is continuing healthcare reforms during the war and says it can share its experience with other countries. International coordination, replacement supplies, and flexible planning would help keep medicines moving despite attacks on production, storage, and distribution points.

A pharmaceutical supply chain is the connected process that gets medicines from production to the people who need them. It includes manufacturing, storage, warehousing, transport, distribution, and final access through healthcare providers or pharmacies. The article describes several of these links being targeted in Ukraine.

The system depends on coordination. A medicine must be produced, kept safely, moved through warehouses or storage sites, and delivered when patients need it. Damage at one point can reduce supplies or delay treatment. Damage at several points can create broader shortages and make demand harder to predict.

Liashko said attacks on warehouses, production facilities, and medicine-storage sites are placing extra pressure on healthcare. The October 4 destruction of the KUSUM plant shows how manufacturing losses affect the chain. He also said Ukraine needs continued partner support because no healthcare system can manage a crisis of this scale alone.